The use of cytotoxic drugs in the surgery of malignant disease.
D000008:Abdominal Neoplasms / Q000188:drug therapy; D000477:Alkylating Agents / Q000008:administration & dosage; D000818:Animals; D000963:Antimetabolites / Q000008:administration & dosage; D000970:Antineoplastic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D002280:Basal Cell Carcinoma / Q000188:drug therapy; D002822:Choriocarcinoma / Q000188:drug therapy; D003520:Cyclophosphamide / Q000008:administration & dosage; D003609:Dactinomycin / Q000008:administration & dosage; D004407:Dysgerminoma / Q000188:drug therapy; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage; D006257:Head; D006258:Head and Neck Neoplasms / Q000188:drug therapy; D006689:Hodgkin Disease / Q000188:drug therapy; D006801:Humans; D007269:Injections, Intra-Arterial; D007866:Leg; D008545:Melanoma / Q000188:drug therapy; D008558:Melphalan / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage; D009362:Neoplasm Metastasis / Q000188:drug therapy; D009364:Neoplasm Recurrence, Local / Q000188:drug therapy; D009369:Neoplasms / Q000188:drug therapy / Q000601:surgery*; D009588:Nitrogen Mustard Compounds / Q000008:administration & dosage; D011247:Pregnancy; D012509:Sarcoma / Q000188:drug therapy; D012512:Sarcoma, Ewing / Q000188:drug therapy; D012878:Skin Neoplasms / Q000188:drug therapy; D014747:Vinblastine / Q000008:administration & dosage; D009396:Wilms Tumor / Q000188:drug therapy
D000477:Alkylating Agents; D000963:Antimetabolites; D000970:Antineoplastic Agents; D009588:Nitrogen Mustard Compounds; D003609:Dactinomycin; D014747:Vinblastine; D003520:Cyclophosphamide; D008558:Melphalan; D005472:Fluorouracil; D008727:Methotrexate